摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(non-1-enyl)-4-hydroxyquinoline N-oxide

中文名称
——
中文别名
——
英文名称
2-(non-1-enyl)-4-hydroxyquinoline N-oxide
英文别名
1-hydroxy-2-non-1-enylquinolin-4-one
2-(non-1-enyl)-4-hydroxyquinoline N-oxide化学式
CAS
——
化学式
C18H23NO2
mdl
——
分子量
285.4
InChiKey
LOUOCBKBIWBTTR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.4
  • 重原子数:
    21
  • 可旋转键数:
    7
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    40.5
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • COMPOUND FOR USE AGAINST PATHOGENIC NEISSERIA AND HAEMOPHILUS SPECIES AND MORAXELLA CATARRHALIS
    申请人:Universität Konstanz
    公开号:EP3502095A1
    公开(公告)日:2019-06-26
    The present invention relates to a compound, which can be used in the prevention and treatment of infections with pathogenic Neisseria species, in particular N. gonorrhoeae and N. meningitidis (the gonococcus and the meningococcus, respectively), and other pathogenic bacteria (e.g. Haemophilus species or Moraxella catarrhalis ), and which can be used for disinfecting a substrate from said bacteria. Moreover, the present invention relates to a corresponding pharmaceutical composition comprising said compound.
    本发明涉及一种化合物,可用于预防和治疗致病奈瑟菌属(特别是淋病奈瑟菌和脑膜炎奈瑟菌)以及其他致病细菌(例如衣原体属或喜马拉雅猫杆菌)感染,并可用于消毒受到这些细菌污染的基质。此外,本发明涉及包含该化合物的相应药物组合物。
  • Compound for Use Against Pathogenic Neisseria and Haemophilus Species and Moraxella Catarrhalis
    申请人:Universität Konstanz
    公开号:US20210169869A1
    公开(公告)日:2021-06-10
    The present invention relates to a compound, which can be used in the prevention and treatment of infections with pathogenic Neisseria species, in particular N. gonorrhoeae and N. meningitidis (the gonococcus and the meningococcus, respectively), and other pathogenic bacteria (e.g. Haemophilus species or Moraxella catarrhalis ), and which can be used for disinfecting a substrate from said bacteria. Moreover, the present invention relates to a corresponding pharmaceutical composition comprising said compound.
查看更多